• Home
  • About Us
    • About ReNeuron
    • Board of Directors
    • Senior Management
    • Advisory Board
    • Working at ReNeuron
    • Patents
  • Products
    • Our Products & Technologies
    • hRPCs for Retinal Disease
    • CTX cells for Stroke Disability
    • CTX-derived Exosomes
    • Induced pluripotent stem cell (iPSC) Platform
    • ReNcell Products
    • Publications
  • Clinical Trials
    • Clinical Trials
    • Phase I/IIa clinical trial in retinitis pigmentosa
    • Phase IIb Clinical trial in stroke disability (PISCES III)
    • Phase IIa clinical trial in stroke disability (PISCES-II)
    • Phase I clinical trial in stroke disability (PISCES)
    • Observational study in stroke
  • News
    • News Centre
    • News
    • Events
    • Media Coverage
  • Investors
    • Investor Centre
    • Corporate Governance
    • Share Price Information
    • Major Shareholdings
    • Advisors
    • Analyst Research
    • Financial Reports
    • General Meetings
    • Webcasts and Presentations
    • Financial Calendar
    • Email alerts
    • RNS Notifications
    • Documents and Circulars
    • AIM Rule 26
    • Declarations
  • Contact
    • Contact Us
ReNeuron logo
ReNeuron logo
  • Home
  • About Us
    • About ReNeuron
    • Board of Directors
    • Senior Management
    • Advisory Board
    • Working at ReNeuron
    • Patents
  • Products
    • Our Products & Technologies
    • hRPCs for Retinal Disease
    • CTX cells for Stroke Disability
    • CTX-derived Exosomes
    • Induced pluripotent stem cell (iPSC) Platform
    • ReNcell Products
    • Publications
  • Clinical Trials
    • Clinical Trials
    • Phase I/IIa clinical trial in retinitis pigmentosa
    • Phase IIb Clinical trial in stroke disability (PISCES III)
    • Phase IIa clinical trial in stroke disability (PISCES-II)
    • Phase I clinical trial in stroke disability (PISCES)
    • Observational study in stroke
  • News
    • News Centre
    • News
    • Events
    • Media Coverage
  • Investors
    • Investor Centre
    • Corporate Governance
    • Share Price Information
    • Major Shareholdings
    • Advisors
    • Analyst Research
    • Financial Reports
    • General Meetings
    • Webcasts and Presentations
    • Financial Calendar
    • Email alerts
    • RNS Notifications
    • Documents and Circulars
    • AIM Rule 26
    • Declarations
  • Contact
    • Contact Us

Events

ReNeuron is presenting at the following events.

 
SelectBIO EV-based Diagnostics, Delivery & Therapeutics 2020

Start date: February 17, 2020
End date: February 18, 2020
Location: San Diego, USA

More information
LSX World Congress 2020

Start date: February 4, 2020
End date: February 5, 2020
Location: London

More information
SelectBIO Exosomes/EVs Therapeutics Summit 2019

Start date: November 1, 2019
End date: November 1, 2019
Location: Rotterdam, The Netherlands

More information
European Society of Gene & Cell Therapy 27th Annual Congress 2019

Start date: October 22, 2019
End date: October 25, 2019
Location: Barcelona International Convention Centre, Barcelona

More information
American Academy of Ophthalmology – AAO 2019

Start date: October 12, 2019
End date: October 15, 2019
Location: Moscone Center, San Francisco

More information
Exosome Based Therapeutic Development Summit 2019

Start date: September 18, 2019
End date: September 19, 2019
Location: Boston, USA

More information
The Ophthalmology Futures Retina Forum

Start date: September 4, 2019
End date: September 4, 2019
Location: Pavillon d’Armenonville, Paris, France

More information
Jefferies 2019 Healthcare Conference

Start date: June 4, 2019
End date: June 7, 2019
Location: New York

More information
Allogeneic Cell Therapies Summit 2019

Start date: May 7, 2019
End date: May 9, 2019
Location: Boston, USA

More information
ARVO Annual Meeting 2019

Start date: April 28, 2019
End date: May 2, 2019
Location: Vancouver

More information
Page 2 of 71234567

Section: News

  • News Centre
  • News
    • News Archive
  • Events
  • Media Coverage

Subscribe here for our Press Releases:

The information collected will be used to send you the information you have requested and to provide information that may be useful to you. ReNeuron may share non-personal aggregate statistics (group) data about ReNeuron’s website visitors with partners or other parties. However, ReNeuron will not sell or share any information about individual users. Please ensure you have read the full contents of our Privacy Notice before continuing. If you agree to your information being used in this way, please tick the box: 

© ReNeuron Group plc 2021 All rights reserved

Website design by Carr Kamasa Design

  • Privacy Notice
  • Disclaimer